In vivo efficacy of the CD40 agonist antibody CP-870,893 against a broad range of tumor types: Impact of tumor CD40 expression, dendritic cells, and chemotherapy.

被引：0
|
作者：
Gladue, R. P. [1 ]
Cole, S. H. [1 ]
Donovan, C. [1 ]
Paradis, T. [1 ]
Alpert, R. [1 ]
Natoli, E. [1 ]
Bedian, V. [1 ]
机构：
[1] Pfizer Global Res & Dev, Groton, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：103S / 103S
页数：1
相关论文
共 50 条
  • [21] Anti-tumor effect against human carcinoma cells by dendritic cells transfected with CD40 ligand
    Tomihara, K
    Kato, K
    Masuta, Y
    Nakamura, K
    Hiratsuka, H
    Hamada, H
    JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 396 - 396
  • [22] Advantages of human CD40 activated dendritic cells for presentation of human tumor antigens
    Schultze, JL
    Michalak, S
    Seamon, MJ
    Delgado, JC
    Gribben, JG
    Nadler, LM
    BLOOD, 1996, 88 (10) : 636 - 636
  • [23] Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10
    Shurin, MR
    Yurkovetsky, ZR
    Tourkova, IL
    Balkir, L
    Shurin, GV
    INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (01) : 61 - 68
  • [24] Lentiviral vector-mediated expression of tumor antigens and CD40 ligand into dendritic cells for cancer immunotherapy
    Chinnasamy, N
    Neuenfeldt, J
    Chinnasamy, D
    CANCER GENE THERAPY, 2003, 10 : S34 - S34
  • [25] Identification and characterization of a human CD40 agonist antibody with efficacy against human tumors in SCID mice
    Gladue, R. P.
    Bedian, V.
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Anti-tumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand
    Kimura, T
    Ohashi, T
    Kikuchi, T
    Naruoka, T
    Kiyota, H
    Eto, Y
    Ohishi, Y
    MOLECULAR THERAPY, 2003, 7 (05) : S117 - S118
  • [27] Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
    Liu, Hsuan-Chen
    Davila Gonzalez, Daniel
    Viswanath, Dixita Ishani
    Vander Pol, Robin Shae
    Saunders, Shani Zakiya
    Di Trani, Nicola
    Xu, Yitian
    Zheng, Junjun
    Chen, Shu-Hsia
    Chua, Corrine Ying Xuan
    Grattoni, Alessandro
    ADVANCED SCIENCE, 2023, 10 (09)
  • [28] Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40+ and CD40- plasmacytoma cells
    Dotti, G
    Savoldo, B
    Yotnda, P
    Rill, D
    Brenner, MK
    BLOOD, 2002, 100 (01) : 200 - 207
  • [29] Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells
    Kikuchi, T
    Crystal, RG
    HUMAN GENE THERAPY, 1999, 10 (08) : 1375 - 1387
  • [30] INDUCTION OF CYTOTOXIC EFFECTOR CELLS TOWARDS CHOLANGIOCELLULAR TUMOR CELLS VIA ACTIVATION OF THE IMMUNE CHECKPOINT CD40/CD40L ON DENDRITIC CELLS
    Mohr, Raphael
    Vogt, Annabelle
    Mahn, Robert
    Van Beekum, Katrin
    Weismueller, Tobias J.
    Branchi, Vittorio
    Matthaei, Hanno
    Toma, Marieta
    Schmidt-Wolf, Ingo
    Kalff, Joerg C.
    Strassburg, Christian P.
    Gonzalez-Carmona, Maria A.
    HEPATOLOGY, 2019, 70 : 1209A - 1209A
12345